Can a serious teratoma lead to death?

Because there are many ways to treat teratoma, patients are advised to pay attention to teratoma examinations and let doctors make treatment choices based on the patient's teratoma condition. Such treatment will be of greater significance. So, will severe teratoma lead to death?

There are indeed benign and malignant teratomas, but malignant teratomas are different from other ovarian malignant tumors. Teratomas are formed by another embryo during embryonic development and do not belong to the patient's own tissue. Neither benign nor malignant represents the nature of the patient's own ovarian tissue. As long as the operation is delicate and the technique is skilled, the teratoma can be completely separated and the patient's own ovarian tissue can be retained. Therefore, no matter whether the teratoma is benign or malignant, the ovaries do not need to be removed. Laparoscopic surgery is limited by the incision, the field of view is small, and the operation is difficult. It is often not easy to peel off the teratoma tissue cleanly. Laparoscopic surgery has a wide field of view and a magnifying effect. Putting the ovary where the teratoma is located in a plastic bag can completely remove the teratoma tissue without contaminating the abdominal cavity. At the same time, it is convenient to explore the contralateral ovary. Therefore, teratoma surgery does not require laparotomy. On the consent form for surgery, if there is a possibility of switching to laparotomy or malignant teratoma requires ovarian removal, do not sign it. This means that the hospital is not skilled in laparoscopic technology and does not have a sufficient understanding of malignant teratoma. Once the ovaries are removed, the patient will soon enter menopause, and there is no way to save the land. It should be considered as overtreatment.
Teratomas originate from potentially multifunctional primitive embryonic cells. They are mostly benign and not life-threatening, but their malignant tendency increases with age. The site of occurrence is related to the midline anterior axis or midline paracentral area of ​​the embryological body cavity, and are often seen in the sacral and coccygeal regions, mediastinum, retroperitoneum, and gonadal regions. They are more common in newborns and infants, and more common in women. Therefore, if you have the disease, you should seek early treatment to avoid threats to your life.